Desyrel: Restoring Restful Sleep and Emotional Balance
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.80 | $48.26 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $72.39 $62.33 (14%) | 🛒 Add to cart |
| 120 | $0.64 | $96.51 $76.41 (21%) | 🛒 Add to cart |
| 180 | $0.59 | $144.77 $105.56 (27%) | 🛒 Add to cart |
| 270 | $0.55 | $217.16 $147.79 (32%) | 🛒 Add to cart |
| 360 | $0.53
Best per pill | $289.54 $190.01 (34%) | 🛒 Add to cart |
Synonyms | |||
Desyrel (trazodone hydrochloride) is a prescription medication belonging to the class of serotonin antagonist and reuptake inhibitors (SARIs). It is primarily indicated for the treatment of major depressive disorder (MDD) but is extensively used off-label for the management of insomnia, particularly where sleep initiation and maintenance are problematic. Its unique pharmacological profile offers a distinct alternative to traditional sedative-hypnotics and first-line antidepressants, providing both antidepressant and soporific effects with a generally favorable side effect and safety spectrum. This makes it a valuable tool in the psychopharmacological armamentarium for clinicians seeking to address comorbid mood and sleep disturbances.
Features
- Active Ingredient: Trazodone Hydrochloride
- Available Dosage Forms: Oral Tablets (50 mg, 100 mg, 150 mg, 300 mg)
- Mechanism of Action: Serotonin Antagonist and Reuptake Inhibitor (SARI)
- Half-Life: Approximately 10-12 hours (biphasic elimination)
- Bioavailability: High, but subject to first-pass metabolism
- Excretion: Primarily renal (70-75%) with some fecal elimination
Benefits
- Effectively alleviates core symptoms of major depressive disorder, including low mood, anhedonia, and psychomotor agitation or retardation.
- Promotes the initiation and maintenance of sleep, improving sleep architecture by increasing slow-wave sleep without significantly suppressing REM sleep.
- Possesses a lower risk of anticholinergic side effects (e.g., dry mouth, constipation, urinary retention) compared to many tricyclic antidepressants.
- Exhibits a lower potential for abuse, dependence, and tolerance development compared to benzodiazepines and other controlled substance sleep aids.
- Generally well-tolerated, with a side effect profile that is often manageable for long-term therapeutic use.
- Can be a suitable option for patients who have not responded adequately to or cannot tolerate first-line SSRI or SNRI antidepressants.
Common use
Desyrel is FDA-approved for the treatment of major depressive disorder (MDD). In clinical practice, its most frequent off-label use is for the management of insomnia, both as a primary condition and when comorbid with depression or anxiety disorders. It is particularly favored for patients who experience sleep-onset insomnia or frequent nighttime awakenings. Its use is also explored in other conditions such as anxiety disorders, fibromyalgia, and as an adjunct agent in certain pain management protocols, though these applications are supported by varying levels of evidence and are not formally approved indications.
Dosage and direction
Dosage must be individualized based on the patient’s condition and response. For the treatment of depression in adults, the initial dose is typically 150 mg per day in divided doses, which may be increased by 50 mg per day every three to four days. The maximum dose for outpatients should not exceed 400 mg per day in divided doses, while inpatients may be given up to 600 mg per day in divided doses. For the management of insomnia, significantly lower doses are commonly employed, often starting at 25 mg to 50 mg taken 30 minutes before bedtime. The tablet should be swallowed whole with a sufficient amount of water and can be taken with or immediately after a light meal or snack to minimize the potential for dizziness or nausea.
Precautions
Patients should be advised that Desyrel may impair mental and/or physical abilities required for the performance of hazardous tasks, such as operating machinery or driving a car, especially during the initial phase of therapy. Caution is recommended when administering Desyrel to patients with a history of cardiac disease, as it can cause arrhythmias, including ventricular tachycardia. Priapism, a prolonged and painful erection, is a rare but serious medical emergency; patients should be instructed to discontinue the drug and seek immediate medical attention if it occurs. Use with caution in patients with a history of seizures, hepatic or renal impairment, or those who are dehydrated or hypovolemic, as these conditions may increase the risk of adverse effects. Patients should be monitored for the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, and mania.
Contraindications
Desyrel is contraindicated in patients with known hypersensitivity to trazodone hydrochloride or any components of the formulation. Its use is also contraindicated during the initial recovery phase following myocardial infarction. Concomitant use with, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs) is contraindicated due to the risk of serotonin syndrome. Initiation of Desyrel in a patient being treated with linezolid or intravenous methylene blue is also contraindicated.
Possible side effect
The most commonly observed side effects are drowsiness, dizziness, lightheadedness, fatigue, and headache. Other frequently reported adverse reactions include dry mouth, nausea, vomiting, blurred vision, constipation, and weight changes. Less common but more serious side effects can include:
- Priapism (prolonged, painful erection)
- Orthostatic hypotension and syncope
- Cardiac arrhythmias (e.g., ventricular tachycardia)
- Serotonin syndrome (agitation, hallucinations, coma, tachycardia, labile blood pressure, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, diarrhea)
- Suicidal thoughts and behaviors
- Mania/hypomania
- Seizures
- Extrapyramidal symptoms
Drug interaction
Desyrel has a significant potential for drug interactions. Concomitant use with other CNS depressants (e.g., alcohol, benzodiazepines, opioids, other sedatives) can potentiate sedation and impairment. It is contraindicated with MAOIs due to the risk of serotonin syndrome. Strong inhibitors of CYP3A4 (e.g., ketoconazole, ritonavir, clarithromycin) can significantly increase trazodone plasma levels, increasing the risk of adverse effects. Conversely, CYP3A4 inducers (e.g., carbamazepine, rifampin) may decrease its efficacy. Use with other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, tramadol) increases the risk of serotonin syndrome. It may potentiate the effects of antihypertensive drugs and increase the risk of hypotension. It can increase digoxin or phenytoin levels. Concomitant use with drugs that prolong the QT interval should be avoided.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not double the next dose to make up for a missed one, as this increases the risk of adverse effects.
Overdose
Overdose of Desyrel can be serious and potentially fatal. Signs and symptoms of overdose may include an exaggeration of its known pharmacological effects: severe drowsiness, dizziness, nausea, vomiting, respiratory depression, hypotension, seizures, and priapism. Cardiac arrest and death have been reported. In cases of suspected overdose, immediate medical attention must be sought. Management is primarily supportive and symptomatic, including securing the airway, ensuring adequate ventilation, and managing hypotension with intravenous fluids and vasopressors if necessary. There is no specific antidote. Gastric lavage may be considered if presented early after ingestion.
Storage
Store Desyrel tablets at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication must be kept in its original container, tightly closed, and out of reach of children and pets. Protect from light, moisture, and excessive heat. Do not store in bathrooms or other damp places. Safely discard any unused or expired medication.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content provided is based on the drug’s prescribing information but may not encompass all possible uses, directions, precautions, or interactions.
Reviews
(Clinical Perspective): Desyrel remains a cornerstone in off-label insomnia treatment due to its efficacy and favorable safety profile compared to controlled substances. Its utility in treating depression with comorbid anxiety and sleep disruption is well-regarded. The main challenge in practice is managing the side effect of next-day somnolence, which often requires careful dose titration. (Patient Perspective): Many users report significant improvement in their ability to fall asleep and stay asleep throughout the night, often noting a more “natural” feeling of sleep compared to other sleep aids. Common complaints include morning grogginess or a “hangover” effect, which sometimes diminishes with continued use or dose adjustment. The low potential for dependency is frequently cited as a major benefit.